Hansoh Pharmaceutical Group Company Limited (HKG: 3692)

Hansoh Pharmaceutical Group Company Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	12,098	10,104	9,382	9,935	8,690	8,683
Revenue Growth (YoY)	27.90%	7.69%	-5.56%	14.33%	0.09%	12.44%
Cost of Revenue	1,087	1,033	870.19	870.39	803.41	737.53
Gross Profit	11,011	9,071	8,512	9,065	7,887	7,945
Selling, General & Admin	4,316	4,241	4,148	4,371	3,862	4,044
Research & Development	2,364	2,097	1,693	1,797	1,252	1,121
Other Operating Expenses	89.74	53.9	63.73	75.91	-	-
Operating Expenses	6,770	6,392	5,905	6,244	5,114	5,165
Operating Income	4,241	2,679	2,607	2,821	2,773	2,780
Interest Expense	-40.88	-66.68	-58.14	-52.82	-1.65	-0.12
Interest & Investment Income	1,065	1,020	331.52	253.85	163.92	179.45
Earnings From Equity Investments	-	-2.12	-13.86	-	-	-
Currency Exchange Gain (Loss)	15.2	4.57	44.56	-9.31	63.37	9.95
Other Non Operating Income (Expenses)	88.78	105.25	117.17	139.34	10.87	9.36
EBT Excluding Unusual Items	5,369	3,741	3,029	3,152	3,009	2,979
Gain (Loss) on Sale of Investments	43.26	23.51	-91.54	144.49	88.91	23.11
Gain (Loss) on Sale of Assets	0.2	2.1	11.24	3.94	-0.04	-1.29
Pretax Income	5,384	3,766	2,948	3,300	3,098	3,001
Income Tax Expense	670.28	488.65	364.68	587.18	529.39	444.18
Net Income	4,714	3,278	2,584	2,713	2,569	2,557
Net Income to Common	4,714	3,278	2,584	2,713	2,569	2,557
Net Income Growth	83.10%	26.85%	-4.76%	5.61%	0.48%	34.35%
Shares Outstanding (Basic)	5,926	5,925	5,916	5,921	5,876	5,477
Shares Outstanding (Diluted)	6,021	6,020	5,929	5,998	5,878	5,477
Shares Change (YoY)	1.34%	1.52%	-1.14%	2.04%	7.31%	9.55%
EPS (Basic)	0.80	0.55	0.44	0.46	0.44	0.47
EPS (Diluted)	0.76	0.52	0.44	0.44	0.44	0.47
EPS Growth	74.26%	19.65%	-1.29%	1.21%	-6.34%	22.64%
Free Cash Flow	4,424	2,897	2,468	2,117	962.83	2,737
Free Cash Flow Per Share	0.73	0.48	0.42	0.35	0.16	0.50
Dividend Per Share	0.315	0.193	0.088	0.073	0.065	-
Dividend Growth	183.17%	118.47%	20.84%	12.44%	-	-
Gross Margin	91.01%	89.78%	90.73%	91.24%	90.75%	91.51%
Operating Margin	35.06%	26.52%	27.79%	28.39%	31.91%	32.02%
Profit Margin	38.97%	32.44%	27.54%	27.31%	29.56%	29.45%
Free Cash Flow Margin	36.57%	28.67%	26.31%	21.31%	11.08%	31.52%
EBITDA	4,617	3,025	2,932	3,084	2,989	2,964
EBITDA Margin	38.16%	29.94%	31.25%	31.04%	34.40%	34.14%
D&A For EBITDA	376.11	345.63	324.37	263.42	216.35	183.68
EBIT	4,241	2,679	2,607	2,821	2,773	2,780
EBIT Margin	35.06%	26.52%	27.79%	28.39%	31.91%	32.02%
Effective Tax Rate	12.45%	12.97%	12.37%	17.79%	17.09%	14.80%

Source: S&P Capital IQ. Standard template. Financial Sources.